Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403). (Q36494159)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403). |
scientific article |
Statements
1 reference
Multicentre prospective phase II trial of gefitinib for advanced non-small cell lung cancer with epidermal growth factor receptor mutations: results of the West Japan Thoracic Oncology Group trial (WJTOG0403). (English)
1 reference
K Tamura
1 reference
I Okamoto
1 reference
T Kashii
1 reference
S Negoro
1 reference
T Hirashima
1 reference
S Kudoh
1 reference
Y Ichinose
1 reference
N Ebi
1 reference
K Shibata
1 reference
T Nishimura
1 reference
N Katakami
1 reference
T Sawa
1 reference
E Shimizu
1 reference
J Fukuoka
1 reference
T Satoh
1 reference
M Fukuoka
1 reference
West Japan Thoracic Oncology Group
1 reference
1 reference
1 reference
Identifiers
1 reference